2024-11-012025-10-312025-10-31false12285144SA-MR SURGICAL CARE LTD2026-10-0986220falseiso4217:GBPxbrli:pure122851442024-10-31122851442025-10-31122851442024-11-012025-10-31122851442023-10-31122851442024-10-31122851442023-11-012024-10-3112285144bus:SmallEntities2024-11-012025-10-3112285144bus:AuditExempt-NoAccountantsReport2024-11-012025-10-3112285144bus:FullAccounts2024-11-012025-10-3112285144bus:PrivateLimitedCompanyLtd2024-11-012025-10-3112285144core:WithinOneYear2025-10-3112285144core:AfterOneYear2025-10-3112285144core:WithinOneYear2024-10-3112285144core:AfterOneYear2024-10-3112285144core:ShareCapital2025-10-3112285144core:SharePremium2025-10-3112285144core:RevaluationReserve2025-10-3112285144core:OtherReservesSubtotal2025-10-3112285144core:RetainedEarningsAccumulatedLosses2025-10-3112285144core:ShareCapital2024-10-3112285144core:SharePremium2024-10-3112285144core:RevaluationReserve2024-10-3112285144core:OtherReservesSubtotal2024-10-3112285144core:RetainedEarningsAccumulatedLosses2024-10-3112285144core:LandBuildings2025-10-3112285144core:PlantMachinery2025-10-3112285144core:Vehicles2025-10-3112285144core:FurnitureFittings2025-10-3112285144core:OfficeEquipment2025-10-3112285144core:NetGoodwill2025-10-3112285144core:IntangibleAssetsOtherThanGoodwill2025-10-3112285144core:ListedExchangeTraded2025-10-3112285144core:UnlistedNon-exchangeTraded2025-10-3112285144core:LandBuildings2024-10-3112285144core:PlantMachinery2024-10-3112285144core:Vehicles2024-10-3112285144core:FurnitureFittings2024-10-3112285144core:OfficeEquipment2024-10-3112285144core:NetGoodwill2024-10-3112285144core:IntangibleAssetsOtherThanGoodwill2024-10-3112285144core:ListedExchangeTraded2024-10-3112285144core:UnlistedNon-exchangeTraded2024-10-3112285144core:LandBuildings2024-11-012025-10-3112285144core:PlantMachinery2024-11-012025-10-3112285144core:Vehicles2024-11-012025-10-3112285144core:FurnitureFittings2024-11-012025-10-3112285144core:OfficeEquipment2024-11-012025-10-3112285144core:NetGoodwill2024-11-012025-10-3112285144core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3112285144core:ListedExchangeTraded2024-11-012025-10-3112285144core:UnlistedNon-exchangeTraded2024-11-012025-10-3112285144core:MoreThanFiveYears2024-11-012025-10-3112285144core:Non-currentFinancialInstruments2025-10-3112285144core:Non-currentFinancialInstruments2024-10-3112285144dpl:CostSales2024-11-012025-10-3112285144dpl:DistributionCosts2024-11-012025-10-3112285144core:LandBuildings2024-11-012025-10-3112285144core:PlantMachinery2024-11-012025-10-3112285144core:Vehicles2024-11-012025-10-3112285144core:FurnitureFittings2024-11-012025-10-3112285144core:OfficeEquipment2024-11-012025-10-3112285144dpl:AdministrativeExpenses2024-11-012025-10-3112285144core:NetGoodwill2024-11-012025-10-3112285144core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3112285144dpl:GroupUndertakings2024-11-012025-10-3112285144dpl:ParticipatingInterests2024-11-012025-10-3112285144dpl:GroupUndertakingscore:ListedExchangeTraded2024-11-012025-10-3112285144core:ListedExchangeTraded2024-11-012025-10-3112285144dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-11-012025-10-3112285144core:UnlistedNon-exchangeTraded2024-11-012025-10-3112285144dpl:CostSales2023-11-012024-10-3112285144dpl:DistributionCosts2023-11-012024-10-3112285144core:LandBuildings2023-11-012024-10-3112285144core:PlantMachinery2023-11-012024-10-3112285144core:Vehicles2023-11-012024-10-3112285144core:FurnitureFittings2023-11-012024-10-3112285144core:OfficeEquipment2023-11-012024-10-3112285144dpl:AdministrativeExpenses2023-11-012024-10-3112285144core:NetGoodwill2023-11-012024-10-3112285144core:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-3112285144dpl:GroupUndertakings2023-11-012024-10-3112285144dpl:ParticipatingInterests2023-11-012024-10-3112285144dpl:GroupUndertakingscore:ListedExchangeTraded2023-11-012024-10-3112285144core:ListedExchangeTraded2023-11-012024-10-3112285144dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-11-012024-10-3112285144core:UnlistedNon-exchangeTraded2023-11-012024-10-3112285144core:NetGoodwill2025-10-3112285144core:IntangibleAssetsOtherThanGoodwill2025-10-3112285144core:LandBuildings2025-10-3112285144core:PlantMachinery2025-10-3112285144core:Vehicles2025-10-3112285144core:FurnitureFittings2025-10-3112285144core:OfficeEquipment2025-10-3112285144core:AfterOneYear2025-10-3112285144core:WithinOneYear2025-10-3112285144core:ListedExchangeTraded2025-10-3112285144core:UnlistedNon-exchangeTraded2025-10-3112285144core:ShareCapital2025-10-3112285144core:SharePremium2025-10-3112285144core:RevaluationReserve2025-10-3112285144core:OtherReservesSubtotal2025-10-3112285144core:RetainedEarningsAccumulatedLosses2025-10-3112285144core:NetGoodwill2024-10-3112285144core:IntangibleAssetsOtherThanGoodwill2024-10-3112285144core:LandBuildings2024-10-3112285144core:PlantMachinery2024-10-3112285144core:Vehicles2024-10-3112285144core:FurnitureFittings2024-10-3112285144core:OfficeEquipment2024-10-3112285144core:AfterOneYear2024-10-3112285144core:WithinOneYear2024-10-3112285144core:ListedExchangeTraded2024-10-3112285144core:UnlistedNon-exchangeTraded2024-10-3112285144core:ShareCapital2024-10-3112285144core:SharePremium2024-10-3112285144core:RevaluationReserve2024-10-3112285144core:OtherReservesSubtotal2024-10-3112285144core:RetainedEarningsAccumulatedLosses2024-10-3112285144core:NetGoodwill2023-10-3112285144core:IntangibleAssetsOtherThanGoodwill2023-10-3112285144core:LandBuildings2023-10-3112285144core:PlantMachinery2023-10-3112285144core:Vehicles2023-10-3112285144core:FurnitureFittings2023-10-3112285144core:OfficeEquipment2023-10-3112285144core:AfterOneYear2023-10-3112285144core:WithinOneYear2023-10-3112285144core:ListedExchangeTraded2023-10-3112285144core:UnlistedNon-exchangeTraded2023-10-3112285144core:ShareCapital2023-10-3112285144core:SharePremium2023-10-3112285144core:RevaluationReserve2023-10-3112285144core:OtherReservesSubtotal2023-10-3112285144core:RetainedEarningsAccumulatedLosses2023-10-3112285144core:AfterOneYear2024-11-012025-10-3112285144core:WithinOneYear2024-11-012025-10-3112285144core:Non-currentFinancialInstrumentscore:CostValuation2024-11-012025-10-3112285144core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-012025-10-3112285144core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-012025-10-3112285144core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-012025-10-3112285144core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-012025-10-3112285144core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-012025-10-3112285144core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3112285144core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3112285144core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3112285144core:Non-currentFinancialInstrumentscore:CostValuation2025-10-3112285144core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-10-3112285144core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-10-3112285144core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-10-3112285144core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-10-3112285144core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-10-3112285144core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-10-3112285144core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-10-3112285144core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-10-3112285144core:Non-currentFinancialInstrumentscore:CostValuation2024-10-3112285144core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-3112285144core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-3112285144core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-3112285144core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-3112285144core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-3112285144core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-3112285144core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-3112285144core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-3112285144bus:Director12024-11-012025-10-3112285144bus:Director22024-11-012025-10-31

SA-MR SURGICAL CARE LTD

Registered Number
12285144
(England and Wales)

Unaudited Financial Statements for the Year ended
31 October 2025

SA-MR SURGICAL CARE LTD
Company Information
for the year from 1 November 2024 to 31 October 2025

Directors

OMAR, Kazal Ahmad, Dr
SALIH, Ali Kadir

Registered Address

1 Bowhay
Hutton Mount
Brentwood
CM13 2JX

Registered Number

12285144 (England and Wales)
SA-MR SURGICAL CARE LTD
Balance Sheet as at
31 October 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets4948,170911,114
948,170911,114
Current assets
Debtors20,165-
Cash at bank and on hand1,656,6031,425,277
1,676,7681,425,277
Creditors amounts falling due within one year5(218,439)(359,627)
Net current assets (liabilities)1,458,3291,065,650
Total assets less current liabilities2,406,4991,976,764
Net assets2,406,4991,976,764
Capital and reserves
Called up share capital100100
Profit and loss account2,406,3991,976,664
Shareholders' funds2,406,4991,976,764
The financial statements were approved and authorised for issue by the Board of Directors on 9 October 2026, and are signed on its behalf by:
OMAR, Kazal Ahmad, Dr
Director
SALIH, Ali Kadir
Director

Registered Company No. 12285144
SA-MR SURGICAL CARE LTD
Notes to the Financial Statements
for the year ended 31 October 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
2.Average number of employees

20252024
Average number of employees during the year22
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 November 2424,00024,000
At 31 October 2524,00024,000
Amortisation and impairment
At 01 November 2424,00024,000
At 31 October 2524,00024,000
Net book value
At 31 October 25--
At 31 October 24--
4.Tangible fixed assets

Plant & machinery

Vehicles

Total

£££
Cost or valuation
At 01 November 24911,114-911,114
Additions-37,05637,056
At 31 October 25911,11437,056948,170
Net book value
At 31 October 25911,11437,056948,170
At 31 October 24911,114-911,114
5.Creditors: amounts due within one year

2025

2024

££
Bank borrowings and overdrafts62,10240,756
Taxation and social security150,431311,671
Accrued liabilities and deferred income5,9067,200
Total218,439359,627